OBJECTIVE: To collect data on the demand and provision of fertility care in HIV-infected couples in the United Kingdom and data on the etiology of subfertility in this population. DESIGN: A postal questionnaire survey and audit of causes of infertility in HIV-infected women. SETTING: Seventy-four Human Embryology and Fertilisation Authority-registered assisted conception units (ACUs) and 294 genitourinary medicine (GUM) clinics in the United Kingdom were sent questionnaires. PATIENT(S): Sixty-five HIV-infected women attending the Research Clinic at the Chelsea and Westminster ACU. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Number of ACUs treating HIV-infected patients and number of GUM clinics receiving requests for referral, as well as the etiology of subfertility in HIV-infected women attending our clinic. RESULT(S): Response rates from ACUs and GUM clinics were 93% and 63%, respectively. Fourteen ACUs (20%) were treating HIV-infected men; of these, seven (10%) performed sperm washing, but only two (3%) tested sperm for HIV after processing, before use. Nine units (13%) treated HIV-infected women, but only three ACUs (4%) had separate laboratories for handling potentially infected gametes or embryos. Of the 15,211 patients registered in 81 GUM clinics, 4% of the men and 16% of the women had requested advice on conceiving. An audit of the Chelsea and Westminster HIV fertility clinic demonstrated a 40% prevalence of tubal factor infertility in HIV-infected women. CONCLUSION(S): Demand is high, and set to increase, but current suboptimal practice in some centers is placing unaffected partners and the unborn child at risk of seroconversion.
OBJECTIVE: To collect data on the demand and provision of fertility care in HIV-infected couples in the United Kingdom and data on the etiology of subfertility in this population. DESIGN: A postal questionnaire survey and audit of causes of infertility in HIV-infectedwomen. SETTING: Seventy-four Human Embryology and Fertilisation Authority-registered assisted conception units (ACUs) and 294 genitourinary medicine (GUM) clinics in the United Kingdom were sent questionnaires. PATIENT(S): Sixty-five HIV-infectedwomen attending the Research Clinic at the Chelsea and Westminster ACU. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Number of ACUs treating HIV-infectedpatients and number of GUM clinics receiving requests for referral, as well as the etiology of subfertility in HIV-infectedwomen attending our clinic. RESULT(S): Response rates from ACUs and GUM clinics were 93% and 63%, respectively. Fourteen ACUs (20%) were treating HIV-infectedmen; of these, seven (10%) performed sperm washing, but only two (3%) tested sperm for HIV after processing, before use. Nine units (13%) treated HIV-infectedwomen, but only three ACUs (4%) had separate laboratories for handling potentially infected gametes or embryos. Of the 15,211 patients registered in 81 GUM clinics, 4% of the men and 16% of the women had requested advice on conceiving. An audit of the Chelsea and Westminster HIV fertility clinic demonstrated a 40% prevalence of tubal factor infertility in HIV-infectedwomen. CONCLUSION(S): Demand is high, and set to increase, but current suboptimal practice in some centers is placing unaffected partners and the unborn child at risk of seroconversion.
Authors: Lynn T Matthews; Tamaryn Crankshaw; Janet Giddy; Angela Kaida; Jennifer A Smit; Norma C Ware; David R Bangsberg Journal: AIDS Behav Date: 2013-02
Authors: Yimeng Zhang; Shari Margolese; Mark H Yudin; Janet M Raboud; Christina Diong; Trevor A Hart; Heather M Shapiro; Cliff Librach; Matt Gysler; Mona R Loutfy Journal: ISRN Obstet Gynecol Date: 2012-08-16
Authors: Angela Kaida; Lynn T Matthews; Steve Kanters; Jerome Kabakyenga; Conrad Muzoora; A Rain Mocello; Jeffrey N Martin; Peter Hunt; Jessica Haberer; Robert S Hogg; David R Bangsberg Journal: PLoS One Date: 2013-05-21 Impact factor: 3.240
Authors: G Carosi; P Nasta; S Fiore; A Matteelli; R Cauda; E Ferrazzi; E Tamburrini; V Savasi; T Bini; M Ravizza; A Bucceri; F Vichi; R Murri; F Mazzotta; A d'Arminio Monforte Journal: Infection Date: 2009-03-23 Impact factor: 7.455